Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment.

Autor: Ruigrok, Eline A. M.1,2 (AUTHOR) e.ruigrok@erasmusmc.nl, Verkaik, Nicole S.3 (AUTHOR) n.verkaik@erasmusmc.nl, de Blois, Erik1 (AUTHOR) r.deblois@erasmusmc.nl, de Ridder, Corrina1,2 (AUTHOR) c.deridder@erasmusmc.nl, Stuurman, Debra1,2 (AUTHOR) d.stuurman@erasmusmc.nl, Roobol, Stefan J.1,3 (AUTHOR) d.vangent@erasmusmc.nl, Van Gent, Dik C.3 (AUTHOR), de Jong, Marion1 (AUTHOR) julie.nonnekens@gmail.com, Van Weerden, Wytske M.2 (AUTHOR), Nonnekens, Julie1,3 (AUTHOR) j.nonnekens@erasmusmc.nl
Zdroj: International Journal of Molecular Sciences. Jul2022, Vol. 23 Issue 14, p8037-8037. 12p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje